TERT and urinary bladder cancer: AssureMDx analyzes DNA from exfoliated urothelial cells in urine to identify mutations (FGFR3, TERT, HRAS) and methylation changes (OTX1, ONECUT2, TWIST1), allowing for highly accurate detection of bladder cancer.